title: [Mydriatic eye drops for children: Analysis of use].
abstract: Mydriatic eye drops are indicated for ophthalmologic exams (fundus and cycloplegic effect for refraction diagnosis). Their use must be optimal to avoid adverse reactions. This is even more important in pediatrics, because few clinical studies were conducted in this population during drug development. We reviewed the use of mydriatic eye drops, gathering information from the Summary of Product Characteristics (SPC) from the Theriaque®database (CNHIM) and the manufacturers' information, in terms of dose, concentration and volume administered, age limit indications, recommendations for administration, and our local practice. This tool is useful in our hospital for physicians, pharmacists, and nurses but could be also useful for all healthcare providers using mydriatic eye drops for children.
authors.affiliation: Inserm, U1123, ECEVE, département de pharmacie, 48, boulevard Sérurier, 75019 Paris, France; Coordination de la gestion des risques associés aux soins et à la prise en charge médicamenteuse, AP-HP, hôpital universitaire Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France.
authors.forename: R
authors.initials: R
authors.lastname: Dumont
authors.affiliation: Service d'ophtalmologie, 48, boulevard Sérurier, 75019 Paris, France; Coordination de la gestion des risques associés aux soins et à la prise en charge médicamenteuse, AP-HP, hôpital universitaire Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Bui Quoc
authors.affiliation: Coordination de la gestion des risques associés aux soins et à la prise en charge médicamenteuse, AP-HP, hôpital universitaire Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Ajzenfisz
authors.affiliation: Inserm, U1123, ECEVE, département de pharmacie, 48, boulevard Sérurier, 75019 Paris, France; Coordination de la gestion des risques associés aux soins et à la prise en charge médicamenteuse, AP-HP, hôpital universitaire Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France.
authors.forename: O
authors.initials: O
authors.lastname: Bourdon
authors.affiliation: Inserm, U1123, ECEVE, département de pharmacie, 48, boulevard Sérurier, 75019 Paris, France; Coordination de la gestion des risques associés aux soins et à la prise en charge médicamenteuse, AP-HP, hôpital universitaire Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France. Electronic address: sonia.prot-labarthe@aphp.fr.
authors.forename: S
authors.initials: S
authors.lastname: Prot-Labarthe
mesh_terms: D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D000075203:Contraindications, Drug; D004305:Dose-Response Relationship, Drug; D005128:Eye Diseases / Q000175:diagnosis*; D005654:Fundus Oculi; D006801:Humans; D007223:Infant; D009184:Mydriatics / Q000008:administration & dosage* / Q000009:adverse effects; D009883:Ophthalmic Solutions; D012029:Refraction, Ocular
chemical_list: D009184:Mydriatics; D009883:Ophthalmic Solutions